Comprehensive Psychiatry
Volume 48, Issue 5 , Pages 395-399 , September 2007

The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief

  • Naomi M. Simon

      Affiliations

    • Massachusetts General Hospital and Harvard Medical School
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 726 7913; fax: +1 617 643 3080.
    • ,
  • Katherine M. Shear

      Affiliations

    • Columbia University School of Social Work
    • ,
  • Elizabeth H. Thompson

      Affiliations

    • Massachusetts General Hospital and Harvard Medical School
    • ,
  • Alyson K. Zalta

      Affiliations

    • Massachusetts General Hospital and Harvard Medical School
    • ,
  • Carol Perlman

      Affiliations

    • Massachusetts General Hospital and Harvard Medical School
    • ,
  • Charles F. Reynolds

      Affiliations

    • University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic
    • ,
  • Ellen Frank

      Affiliations

    • University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic
    • ,
  • Nadine M. Melhem

      Affiliations

    • University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic
    • ,
  • Russell Silowash

      Affiliations

    • University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic

References 

  1. Shear K, Frank E, Houck PR, Reynolds CF. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005;293(21):2601–2608
  2. Monk TH, Houck PR, Shear MK. The daily life of complicated grief patients—what gets missed, what gets added?. Death Stud. 2006;30(1):77–85
  3. Shear K, Jackson C, Essock S, Donahue S, Felton C. Screening for complicated grief among Project Liberty service recipients 18 months after September 11, 2001. Psychiatr Serv. 2006;57(9):1–7
  4. Silverman GK, Jacobs SC, Kasl SV, Shear MK, Maciejewski PK, Noaghiul FS, et al. Quality of life impairments associated with diagnostic criteria for traumatic grief. Psychol Med. 2000;30(4):857–862
  5. Prigerson HG, Bridge J, Maciejewski PK, Beery LC, Rosenheck RA, Jacobs SC, et al. Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry. 1999;156(12):1994–1995
  6. Prigerson HG, Bierhals AJ, Kasl SV, Reynolds CF, Shear MK, Day N, et al. Traumatic grief as a risk factor for mental and physical morbidity. Am J Psychiatry. 1997;154(5):616–623
  7. Szanto K, Prigerson H, Houck P, Ehrenpreis L, Reynolds CF. Suicidal ideation in elderly bereaved: the role of complicated grief. Suicide Life Threat Behav. 1997;27(2):194–207
  8. Szanto K, Shear MK, Houck PR, Reynolds CF, Frank E, Caroff K, et al. Indirect self-destructive behavior and overt suicidality in patients with complicated grief. J Clin Psychiatry. 2006;67(2):233–239
  9. Latham AE, Prigerson HG. Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav. 2004;34:350–362
  10. Horowitz MJ, Siegel B, Holen A, Bonanno GA, Milbrath C, Stinson CH. Diagnostic criteria for complicated grief disorder. Am J Psychiatry. 1997;154(7):904–910
  11. Jacobs S, Mazure C, Prigerson HG. Diagnostic criteria for traumatic grief. Death Stud. 2000;24:185–199
  12. Lichtenthal WG, Cruess DG, Prigerson HG. A case for establishing complicated grief as a distinct mental disorder in DSM-V. Clin Psychol Rev. 2004;24(6):637–662
  13. Prigerson HG, Shear MK, Jacobs SC, Reynolds CF, Maciejewski PK, Davidson JR, et al. Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry. 1999;174:67–73
  14. Prigerson HG, Maciejewski PK, Reynolds CF, Bierhals AJ, Newsom JT, Fasiczka A, et al. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res. 1995;59(1-2):65–79
  15. Shear MK, Monk T, Houck P, Melhem N, Frank E, Reynolds C, et al. Avoidance among patients with complicated grief. Eur Arch Psychiatry Clin Neurosci [in press].
  16. Langner R, Maercker A. Complicated grief as a stress response disorder: evaluating diagnostic criteria in a German sample. J Psychosom Res. 2005;58(3):235–242
  17. Melhem NM, Rosales C, Karageorge J, Reynolds CF, Frank E, Shear MK. Comorbidity of axis I disorders in patients with traumatic grief. J Clin Psychiatry. 2001;62(11):884–887
  18. Prigerson HG, Bierhals AJ, Kasl SV, Reynolds CF, Shear MK, Newsom JT, et al. Complicated grief as a disorder distinct from bereavement-related depression and anxiety: a replication study. Am J Psychiatry. 1996;153(11):1484–1486
  19. Prigerson HG, Frank E, Kasl SV, Reynolds CF, Anderson B, Zubenko GS, et al. Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry. 1995;152(1):22–30
  20. Boelen PA, van den Bout J, de Keijser J. Traumatic grief as a disorder distinct from bereavement-related depression and anxiety: a replication study with bereaved mental health care patients. Am J Psychiatry. 2003;160(7):1339–1341
  21. Stroebe M, Schut H. Complicated grief: a conceptual analysis of the field. Omega. 2005-2006;52(1):53–70
  22. Shear MK, Frank E, Foa E, Cherry C, Reynolds CF, Vander Bilt J, et al. Traumatic grief treatment: a pilot study. Am J Psychiatry. 2001;158(9):1506–1508
  23. First MS, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for Axis I DSM-IV disorders—patient version (SCID-1/P version 2.0). New York: New York State Psychiatric Institute Biometrics Research Department; 1994;
  24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–61
  25. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001;13(4):166–178
  26. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–218
  27. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213
  28. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–464
  29. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627
  30. Simon NM, Pollack MH, Fischmann D, Perlman CA, Muriel AC, Moore CW, et al. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005;66(9):1105–1110
  31. Bromet E, Sonnega A, Kessler RC. Risk factors for DSM-III-R posttraumatic stress disorder: findings from the National Comorbidity Survey. Am J Epidemiol. 1998;147(4):353–361
  32. Reynolds CF, Miller MD, Pasternak RE, Frank E, Perel JM, Cornes C, et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry. 1999;156(2):202–208

 Naomi Simon is a consultant for Paramount Biosciences and is on the Speaker's Bureau for Continuing Medical Education and other presentations for Forest Laboratories, Janssen, Lilly, Pfizer, Sepracor and UCB Pharma. Dr Simon has participated in clinical trials sponsored by Cephalon, Janssen, UCB Pharma, and Sepracor. Dr Simon has received investigator-initiated grants from AstraZeneca, Cephalon, Forest Laboratories, GlaxoSmithKline, Pfizer, Lilly, the National Institute of Mental Health, and the National Alliance for Research of Schizophrenia and Depression. Katherine Shear is a consultant for Pfizer and receives research grant funding from Forest Laboratories. Charles Reynolds III receives research support in the form of pharmaceutical supplies for National Institutes of Health–sponsored work from GlaxoSmithKline, Forest, Pfizer, Lilly, and Bristol-Myers Squibb. Ellen Frank is a consultant for Pfizer, Eli Lilly, and Novartis. Dr Frank receives grant support from the National Institute of Mental Health and the Forest Research Institute and serves on the advisory board for Pfizer, Eli Lilly, and Servier. Nadine Melhem has received a travel award from the American Foundation for Suicide Prevention. All other authors declare that they have no conflicts of interest.

PII: S0010-440X(07)00058-2

doi: 10.1016/j.comppsych.2007.05.002

Comprehensive Psychiatry
Volume 48, Issue 5 , Pages 395-399 , September 2007

Article Tools

* Image Usage & Resolution